✦ LIBER ✦

Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: Impact of interstitial lung disease

✍ Scribed by Stephen C. Mathai; Laura K. Hummers; Hunter C. Champion; Fredrick M. Wigley; Ari Zaiman; Paul M. Hassoun; Reda E. Girgis

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 86 KB
Volume: 60
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.24267

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systemic sclerosis–related pulmonary hyp

Systemic sclerosis–related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies

✍ Jérôme Le Pavec; Reda E. Girgis; Noah Lechtzin; Stephen C. Mathai; David Launay; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

Clinical course of lung physiology in pa

Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study Placebo Group

✍ Dinesh Khanna; Chi-Hong Tseng; Niloofar Farmani; Virginia Steen; Daniel E. Furst 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Pulmonary arterial hypertension is a maj

Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease

✍ Salim Trad; Zahir Amoura; Catherine Beigelman; Julien Haroche; Nathalie Costedoa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

Impact of oral cyclophosphamide on healt

Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: Results from the scleroderma lung study

✍ Dinesh Khanna; Xiaohong Yan; Donald P. Tashkin; Daniel E. Furst; Robert Elashoff 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## Objective To assess the impact of cyclophosphamide (CYC) on the health‐related quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. ## Methods One hundred fifty‐eight subjects participated in the Scleroderma Lung Study, with 79 each randomized to CYC

Persistence of abnormal bronchoalveolar

Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease

✍ Shikha Mittoo; Fredrick M. Wigley; Robert Wise; Huiqing Xiao; Laura Hummers 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 1 views

Risk of interstitial lung disease associ

Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis

✍ Ji Hyeon Ju; Sung-Il Kim; Jun-Hee Lee; Sang-Il Lee; Wan-Hee Yoo; Jung-Yoon Choe; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 1 views